The role of conventional antibodies targeting the CD4 binding site and CD4-induced epitopes in the control of HIV-1 CRF01_AE viruses

Biochem Biophys Res Commun. 2019 Jan 1;508(1):46-51. doi: 10.1016/j.bbrc.2018.11.063. Epub 2018 Nov 20.

Abstract

HIV-1 CRF01_AE viruses are highly prevalent in Southeast Asia. However, vulnerability sites in Env of CRF01_AE viruses have not been investigated sufficiently. We examined the sensitivity of CRF01_AE viruses from Japan and Vietnam, together with subtype B viruses from Japan, to neutralization and Fc-mediated signaling. Neutralization coverage of broadly neutralizing antibodies (bnAbs), 2G12 and b12, was significantly low against CRF01_AE viruses, compared with subtype B viruses. In contrast, the conventional antibody targeting the CD4 binding site (CD4bs), 49G2, showed better neutralization and Fc-mediated signaling activities against CRF01_AE viruses than subtype B viruses. Fc-mediated signaling activity of anti-CD4 induced (CD4i) antibody, 4E9C, was also detected against CRF01_AE viruses more than subtype B viruses. These results suggest that conventional antibodies against CD4bs and CD4i may play an important role in the control of CRF01_AE viruses.

Keywords: Antibody; CRF01_AE; Fc-mediated signaling; HIV-1; Neutralization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Neutralizing / immunology
  • Binding Sites / immunology
  • CD4 Antigens / immunology
  • Epitopes / immunology
  • HIV Antibodies / immunology
  • HIV Infections / immunology*
  • HIV Infections / virology*
  • HIV-1 / classification*
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • Humans
  • Neutralization Tests
  • Receptors, IgG / immunology
  • Signal Transduction / immunology
  • env Gene Products, Human Immunodeficiency Virus / genetics

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • CD4 Antigens
  • Epitopes
  • FCGR3A protein, human
  • HIV Antibodies
  • Receptors, IgG
  • env Gene Products, Human Immunodeficiency Virus